Zhejiang Fangqi Biopharmaceutical Co., Ltd. – Trademark Portfolio
Entity Type: 99
Zhejiang Fangqi Biopharmaceutical Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include COVEQUELL. The owner is based in Hangzhou, Zhejiang.
Xinjie Street, Xiaoshan District,
4F, Building 9, No. 99, Kenhui 8th Road,
Hangzhou, Zhejiang 310000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zhejiang Fangqi Biopharmaceutical Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Zhejiang Fangqi Biopharmaceutical Co., Ltd. have?
Zhejiang Fangqi Biopharmaceutical Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Zhejiang Fangqi Biopharmaceutical Co., Ltd. file in?
Zhejiang Fangqi Biopharmaceutical Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Zhejiang Fangqi Biopharmaceutical Co., Ltd.'s most well-known trademarks?
Zhejiang Fangqi Biopharmaceutical Co., Ltd.'s registered trademark portfolio includes well-known marks such as COVEQUELL. These are among 2 currently registered trademarks in the portfolio.
What is Zhejiang Fangqi Biopharmaceutical Co., Ltd.'s trademark registration success rate?
Zhejiang Fangqi Biopharmaceutical Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.